We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Preattached Holder Protects Phlebotomists Against Needlestick Injury

By LabMedica International staff writers
Posted on 08 Jun 2010
Print article
A push button blood collection set with a preattached holder is now available to protect health care workers from accidental needlestick injuries (NSIs). The ready-to-use product will also prevent reuse of the tube holder.

Needlestick and sharps injuries carry the risk of infections and are an occupational hazard for all healthcare professionals involved in clinical care. The preassembled device saves time by shortening the blood collection process; the preattached holder covers the holder end of the needle, reducing the risk of injury.

The intuitively designed apparatus consists of a large flexible wing flanking the needle, a push button safety mechanism, and tubing that does not kink or coil. This is connected to the single use holder by way of a luer adaptor. The blood collection set is manufactured by Becton, Dickinson and Company (BD; Franklin Lakes, NJ, USA) and is an improved version of the original Vacutainer collection sets. The new product's in-vein activation of the safety device provides split-second protection against NSIs.

Tube holders that are reused have not been disinfected or sterilized, posing unnecessary exposure to blood borne pathogens including human immunodeficiency virus (HIV), hepatitis C virus, and hepatitis B virus. The National Phlebotomy Association (NPA; Landover, MD, USA) recently completed a study on reusable blood tube holders. The study revealed that 99% of holders sampled, were contaminated with blood. This poses an occupational exposure risk to the healthcare worker and an infection-control exposure risk to the patient.

Single-use holders that are preattached to safety-engineered blood collection needles may provide the highest level of infection prevention for the healthcare industry. One hospital reported an 88% reduction in NSIs after adopting the device, with zero NSIs in the final 21 months after implementing the product.

Dr. Ana Stankovic, M.D, Ph.D., M.S.P.H., world VP at BD diagnostics said, "this product virtually eliminates a healthcare worker's exposure to a contaminated needle and reduces the time required to collect blood for diagnostic testing."

Related Links:

Becton, Dickinson and Company
National Phlebotomy Association


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
New
Immunofluorescence Analyzer
MPQuanti

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.